Final Agenda

Tuesday, June 30, 2020
11:00 a.m. – 6:00 p.m. EDT

Chair:

Steven Skates, Ph.D., Massachusetts General Hospital

Co-Chair:

Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center

NCI Program Directors:

Christos Patriotis, Ph.D., and Sharmistha Ghosh-Janjigian, Ph.D., National Cancer Institute

 

11:00 a.m. – 11:05 a.m. EDT Welcome and Introductions

Steven Skates, Ph.D., Massachusetts General Hospital
Christos Patriotis, Ph.D., National Cancer Institute
11:05 a.m. – 11:45 a.m. EDT BGYN01: Objective, Charge and Progress of Collaborative Group

Steven Skates, Ph.D., Massachusetts General Hospital
Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center
11:45 a.m. – 12:25 p.m. EDT Pros and Cons of Pan-Cancer Detection Approach: Should EDRN Increase Focus on Such an Approach?
(10+10 min talk, 20 min discussion)
Moderator:Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center
11:45 a.m. – 11:55 a.m. EDT BGYN02: Noninvasive Multi-Cancer Screening Using Liquid Biopsy
Nicholas Papadopoulos, Ph.D., Johns Hopkins University School of Medicine
11:55 a.m. – 12:05 p.m. EDT BGYN03: Simultaneous Multi-Cancer Detection using a Cell-free Nucleic Acid Assay
Brian Allen, M.S., GRAIL
12:05 p.m. – 12:25 p.m. EDT Discussants:

Steven Skates, Ph.D., Massachusetts General Hospital
Karen Anderson, M.D., Ph.D., Arizona State University/The Biodesign Institute
Zhen Zhang, Ph.D., Johns Hopkins University School of Medicine
12:25 p.m. – 1:05 p.m. EDT Integration of Germline Genomics and Circulating Biomarkers for Early Cancer Detection
(20 min talk, 20 min discussion)
Moderator:Christos Patriotis, Ph.D., National Cancer Institute
12:25 p.m. – 12:45 p.m. EDT BGYN04: Tailoring Early Detection Strategies for Breast and Ovarian Cancer to Genomic Risk
Mary Daly, M.D., Fox Chase Cancer Center
12:45 p.m. – 1:05 p.m. EDT Discussants:

Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center
Robert Bast, M.D., The University of Texas MD Anderson Cancer Center
Yiwey Shieh, M.D., University of California San Francisco
1:05 p.m. – 1:30 p.m. EDT Break
1:30 p.m. – 2:10 p.m. EDT ctDNA for Early Cancer Detection Biomarker Development
(10+10 min talk, 20 min discussion)
Moderator:Sharmistha Ghosh-Janjigian, Ph.D., National Cancer Institute
1:30 p.m. – 1:40 p.m. EDT BGYN05: ctDNA for Early Cancer Detection: Promise, Challenges, and Emerging Solutions
Abhijit Patel, M.D., Ph.D., Yale School of Medicine
1:40 p.m. – 1:50 p.m. EDT BGYN06: Cell-free DNA for Early Cancer Detection
Xianghong Jasmine Zhou, Ph.D., University of California Los Angeles
1:50 p.m. – 2:10 p.m. EDT Discussants:

Nicholas Papadopoulos, Ph.D., Johns Hopkins University School of Medicine
Steven Skates, Ph.D., Massachusetts General Hospital
2:10 p.m. – 2:50 p.m. EDT Exosomes and Early Cancer Detection Biomarker Development
(10+10 min talk, 20 min discussion)
Moderator:Steven Skates, Ph.D., Massachusetts General Hospital
2:10 p.m. – 2:20 p.m. EDT BGYN07: Microfluidics for the Isolation and Tracking of Tumor Extracellular Vesicles
Shannon Stott, Ph.D., Massachusetts General Hospital
2:20 p.m. – 2:30 p.m. EDT BGYN08: Exosome Proteomics For Early Cancer Detection
David Lyden, M.D., Ph.D., Weill Cornell Medicine, Drukier Institute for Children's Health
2:30 p.m. – 2:50 p.m. EDT Discussants:

Johan Skog, Ph.D., Exosome Diagnostics
Andrew Godwin, Ph.D., Kansas University Medical Center
2:50 p.m. – 3:15 p.m. EDT Break
3:15 p.m. – 3:55 p.m. EDT Exploring the Tumor-Associated Lymphoid Cell Compartment for Advancing the Early Cancer Detection Research Space
(10+10 min talk, 20 min discussion)
Moderator:Steven Skates, Ph.D., Massachusetts General Hospital
3:15 p.m. – 3:25 p.m. EDT BGYN09: Detect Early-Stage Cancers From the Blood T cell Repertoire
Bo Li, Ph.D., University of Texas Southwestern
3:25 p.m. – 3:35p.m. EDT BGYN10: Probing the micro-environment of Breast Pre-cancerous lesions
Olivier Harismendy, Ph.D., University of California San Diego
3:35 p.m. – 3:55 p.m. EDT Discussants:

Charles Drescher, M.D., Fred Hutchinson Cancer Research Center
Jeffrey Marks, Ph.D., Duke University Medical Center
3:55 p.m. – 4:35 p.m. EDT Imaging and Artificial Intelligence in Early Cancer Detection
(10+10 min talk, 20 min discussion)
Moderator:Christos Patriotis, Ph.D., National Cancer Institute
3:55 p.m. – 4:05p.m. EDT BGYN11: Mammography AI in EDRN Imaging
Joseph Lo, Ph.D., Duke University
4:05 p.m. – 4:15 p.m. EDT BGYN12: Implementing AI in early cancer detection
Ashish Mahabal, Ph.D., California Institute of Technology/Jet Propulsion Laboratory
4:15 p.m. – 4:35 p.m. EDT Discussants:

Victoria Seewaldt, M.D., City of Hope Comprehensive Cancer Center
Jennifer Barton, Ph.D., University of Arizona
John Heine, Ph.D., H. Lee Moffitt Cancer Center and Research Institute, Inc.
4:35 p.m. – 4:45 p.m. EDT Break
4:45 p.m. – 6:00 p.m. EDT SWOT (Strengths, Weaknesses, Opportunities, and Threats) Analysis
Moderator:
Joshua LaBaer, M.D., Ph.D., Arizona State University/The Biodesign Institute
Discussants:

Karen Anderson, M.D., Ph.D., Arizona State University/The Biodesign Institute
Charles Drescher, M.D., Fred Hutchinson Cancer Research Center
Jeffrey Marks, Ph.D., Duke University Medical Center



Discuss the strengths of EDRN and suggestions to further strengthen the Network
Identify weaknesses and discuss the solutions (Mitigation)
Discuss opportunities and highlight prioritized opportunities
Discuss threats (competing interests/research) and mitigations
6:00 p.m. EDT Adjourn